Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Jiangsu Genscript Probio Biotech Co. Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner and 1 distinct art unit. KODYE LEE ABBOTT is the busiest examiner, responsible for the 1 pending office action. The current prosecution state is highly focused, with only 1 pending office action active. This centralized structure allows the applicant to concentrate all efforts on a single examiner and a single set of art unit guidelines, which can lead to a more efficient prosecution process.
Because this action is assigned to 1 distinct examiner and 1 distinct art unit, the applicant's primary task is to address the specific concerns of KODYE LEE ABBOTT. There are no other examiners or art units involved, which simplifies the strategic approach within the Biotechnology & Pharmaceuticals technology area. Practitioners should focus on the examiner's specific technical expertise to craft effective responses. With only 1 pending office action, the company can ensure that its legal resources are used effectively to secure this particular patent asset, as the entire portfolio's current success depends on this single interaction.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ABBOTT, KODYE LEE | 1 | 53.1% | +71.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18257802 | HEK293T CELL STRAIN HAVING HIGH DISPERSIBILITY AND SCREENING METHOD THEREFOR | ABBOTT, KODYE LEE | — |
| Art Unit | Apps |
|---|---|
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18257802 | HEK293T CELL STRAIN HAVING HIGH DISPERSIBILITY AND SCREENING METHOD THEREFOR | ABBOTT, KODYE LEE | 1634 | §112 | Non-Final OA | — | Pending | Jun 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial